Works matching IS 13518216 AND DT 2021 AND VI 27 AND IP 4
Results: 65
Pharmacokinetic‐guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e450, doi. 10.1111/hae.14336
- By:
- Publication type:
- Article
Prothrombotic variants as modifiers of clinical phenotype in four related individuals with haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e591, doi. 10.1111/hae.14348
- By:
- Publication type:
- Article
Emicizumab reduces re‐hospitalization for bleeding in acquired haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e585, doi. 10.1111/hae.14335
- By:
- Publication type:
- Article
Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e581, doi. 10.1111/hae.14334
- By:
- Publication type:
- Article
Real‐world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e554, doi. 10.1111/hae.14316
- By:
- Publication type:
- Article
Severe bleeding after haemorrhoidal banding in a haemophilia patient treated with emicizumab.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e589, doi. 10.1111/hae.14346
- By:
- Publication type:
- Article
Real‐world cost estimates of initiating emicizumab in US patients with haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 591, doi. 10.1111/hae.14347
- By:
- Publication type:
- Article
Adherence to prophylaxis and its association with activation of self‐management and treatment satisfaction.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 581, doi. 10.1111/hae.14333
- By:
- Publication type:
- Article
Patterns of joint damage in severe haemophilia A treated with prophylaxis.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 666, doi. 10.1111/hae.14345
- By:
- Publication type:
- Article
The effect of age on the pressure pain threshold of asymptomatic ankles and knees in young individuals with haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 683, doi. 10.1111/hae.14344
- By:
- Publication type:
- Article
Inflammation, angiogenesis and sensory nerve sprouting in the synovium of bony ankylosed and not bony ankylosed knees with end‐stage haemophilic arthropathy.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 657, doi. 10.1111/hae.14343
- By:
- Publication type:
- Article
Inherited bleeding disorders in Afghanistan: The current situation amid COVID‐19.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e579, doi. 10.1111/hae.14332
- By:
- Publication type:
- Article
Thromboelastometry detects enhancement of coagulation in blood by emicizumab via intrinsic pathway.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e571, doi. 10.1111/hae.14330
- By:
- Publication type:
- Article
Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 626, doi. 10.1111/hae.14329
- By:
- Publication type:
- Article
On‐demand treatment with the iron chelator deferasirox is ineffective in preventing blood‐induced joint damage in haemophilic mice.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 648, doi. 10.1111/hae.14328
- By:
- Publication type:
- Article
Developing clinical practice guidelines for physiotherapists working with people with inherited bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 674, doi. 10.1111/hae.14327
- By:
- Publication type:
- Article
Addressing the impact of SARS‐CoV‐2 infection in persons with congenital bleeding disorders: The Italian MECCOVID‐19 study.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e575, doi. 10.1111/hae.14331
- By:
- Publication type:
- Article
Successful treatment of COVID‐19 in a patient with severe haemophilia A on emicizumab prophylaxis in the intensive care unit.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e567, doi. 10.1111/hae.14326
- By:
- Publication type:
- Article
Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e563, doi. 10.1111/hae.14323
- By:
- Publication type:
- Article
Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 519, doi. 10.1111/hae.14322
- By:
- Publication type:
- Article
A tailored intervention for illness acceptance improves adherence and quality of life in adults with haemophilia using prophylaxis.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e434, doi. 10.1111/hae.14320
- By:
- Publication type:
- Article
Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e559, doi. 10.1111/hae.14319
- By:
- Publication type:
- Article
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e441, doi. 10.1111/hae.14325
- By:
- Publication type:
- Article
Efficacy and safety of subcutaneous prophylaxis with dalcinonacog alfa in adults with haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 574, doi. 10.1111/hae.14315
- By:
- Publication type:
- Article
An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiency.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 690, doi. 10.1111/hae.14314
- By:
- Publication type:
- Article
Comparative analysis of the pivotal studies of extended half‐life recombinant FVIII products for treatment of haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e422, doi. 10.1111/hae.14313
- By:
- Publication type:
- Article
Clinical and ultrasound evaluation of patients with haemophilia on prophylaxis.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 641, doi. 10.1111/hae.14312
- By:
- Publication type:
- Article
Recurrence of a high‐titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e551, doi. 10.1111/hae.14311
- By:
- Publication type:
- Article
Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre's readiness in United States and EU.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 511, doi. 10.1111/hae.14309
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 699, doi. 10.1111/hae.14308
- Publication type:
- Article
Real‐world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow‐up in a national adult cohort.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 618, doi. 10.1111/hae.14307
- By:
- Publication type:
- Article
The SLIM study—Shared medical appointments to change lifestyles of overweight people with haemophilia: A randomized multiple baseline (n‐of‐1) design.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 606, doi. 10.1111/hae.14306
- By:
- Publication type:
- Article
Successful emicizumab prophylaxis during dual antiplatelet therapy for insertion of drug‐eluting stents after acute coronary syndrome: A case report.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e549, doi. 10.1111/hae.14305
- By:
- Publication type:
- Article
Patients' and parents' satisfaction with, and preference for, haemophilia A treatments: a cross‐sectional, multicentre, observational study.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 563, doi. 10.1111/hae.14304
- By:
- Publication type:
- Article
Challenges in biomarker research in haemophilic arthropathy.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e547, doi. 10.1111/hae.14290
- By:
- Publication type:
- Article
Surgical excision of a pseudotumour under the coverage of the plasma‐derived factor X concentrate in a patient with severe factor X deficiency: A case report.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e543, doi. 10.1111/hae.14289
- By:
- Publication type:
- Article
A fixed 'single vial' dose of subcutaneous desmopressin (DDAVP) produces adequate biologic responses for persons with mild haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e540, doi. 10.1111/hae.14287
- By:
- Publication type:
- Article
Care for children with haemophilia during COVID‐19: Data of the PedNet study group.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e537, doi. 10.1111/hae.14286
- By:
- Publication type:
- Article
Bleeding disorders: Are gynaecologists testing women at risk?
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e534, doi. 10.1111/hae.14283
- By:
- Publication type:
- Article
A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 544, doi. 10.1111/hae.14282
- By:
- Publication type:
- Article
Isokinetic knee strength deficit in patients with moderate haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 634, doi. 10.1111/hae.14279
- By:
- Publication type:
- Article
A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma).
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e530, doi. 10.1111/hae.14273
- By:
- Publication type:
- Article
Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 515, doi. 10.1111/hae.14271
- By:
- Publication type:
- Article
Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e525, doi. 10.1111/hae.14268
- By:
- Publication type:
- Article
Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 520, doi. 10.1111/hae.14266
- By:
- Publication type:
- Article
Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID‐19 infection.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e517, doi. 10.1111/hae.14252
- By:
- Publication type:
- Article
Management of a hemispherotomy for Rasmussen encephalitis in a patient with mild factor 10 deficiency and low von Willebrand factor levels.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e513, doi. 10.1111/hae.14249
- By:
- Publication type:
- Article
Early elevation of factor IX level in japanese brothers with Haemophilia B Leyden who are carrying c. ‐35 g > a mutations in the promoter region of F9.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e510, doi. 10.1111/hae.14248
- By:
- Publication type:
- Article
The association between desmopressin exposure, FVIII response and side effects.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e506, doi. 10.1111/hae.14227
- By:
- Publication type:
- Article
Persistent inhibitor in acquired haemophilia A: A case for emicizumab?
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e502, doi. 10.1111/hae.14225
- By:
- Publication type:
- Article